This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Blennow, K. Articles by Wallin, A. Search for Related Content PubMed Articles by Blennow, K. Articles by Wallin, A. Social Bookmarking                         What's this?

Clinical Heterogeneity of Probable Alzheimer's Disease

Department of Psychiatry and Neurochemistry, University of Göteborg, St Jörgen Hospital, Hisings Backa, Sweden.

Anders Wallin, MD, PhD

Department of Psychiatry and Neurochemistry, University of Göteborg, St Jörgen Hospital, Hisings Backa, Sweden.

When the symptomatology in probable Alzheimer's disease (AD) was studied, two subgroups emerged: one with predominant cortical symptoms of parietal type (AD type I) and another with general cognitive symptoms but absence of or only mild cortical symptoms (AD type II). In AD type I, the age at onset was significantly lower, confusional symptoms and leukoariosis on computerized tomographic scan were less frequent, and the ganglioside GM1 concentration in cerebrospinal fluid was significantly higher than in AD type II. Although the significance of changes in cerebrospinal fluid gangliosides has not been fully elucidated, it is possible that the increase in cerebrospinal fluid GM1 reflects a more severe degeneration of neurons and synapses in AD type I than in AD type II. The relation between symptomatology and leukoariosis suggests that leukoariosis has clinical significance in AD patients. The total results suggest heterogeneity of probable AD. AD type I appears to constitute a classic AD subgroup with memory disturbances and marked cortical symptoms of parietal type, while age-related changes, vascular changes, and leukoariosis may be responsible for the more generalized symptomatology in AD type II. (J Geriatr Psychiatry Neurol 1992;5:106–113).

Journal of Geriatric Psychiatry and Neurology, Vol. 5, No. 2, 106-113 (1992)
DOI: 10.1177/002383099200500208


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. A. Van Gool Multiple-Level Studies Are Needed to Assess the True Value of Diagnostic Tests for Dementia Arch Neurol, January 1, 2006; 63(1): 142 - 143. [Full Text] [PDF]